Evidence-based·Last reviewed May 30, 2026·How we grade evidence

Resveratrol

PhytochemicalStilbenoidBest with a meal

Useful mainly for adults with metabolic risk factors (prediabetes, dyslipidemia) interested in polyphenol research; evidence remains largely at biomarker level.

Quick decision guide

May help most

Adults with metabolic risk factors (prediabetes, dyslipidemia) interested in polyphenol research; evidence remains largely at biomarker level

Common dosing range

100–500 mg/day of trans-resveratrol

When to expect effects

Weeks to months for biomarker effects

Watch out for

Estrogenic activity — avoid in hormone-sensitive cancers; antiplatelet effect — caution with anticoagulants

What is it

Resveratrol is a plant polyphenol (stilbene) found in grape skins, red wine, peanuts, and Japanese knotweed. It is produced by plants as a defense response to stress and has been studied for cardiovascular, metabolic, and longevity-related effects.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if

You have metabolic risk factors and are interested in polyphenol supplementation alongside diet and exercise
You are a researcher or n=1 experimenter who understands the evidence is primarily preclinical

Probably skip if

You have hormone-sensitive cancer (breast, endometrial, ovarian) — estrogenic activity is a concern
You take anticoagulants — antiplatelet activity may increase bleeding risk
You expect life-extension or anti-aging outcomes — human evidence does not support these claims

Evidence at a glance

cardiovascular biomarker improvement

Limited Evidence
Effect
Small and inconsistent improvements in lipid, inflammatory, and endothelial markers
Best fit
Adults with cardiovascular risk factors (dyslipidemia, hypertension)
Time
8–24 weeks

insulin sensitivity and glucose metabolism

Limited Evidence
Effect
Modest and inconsistent HOMA-IR reductions in some trials
Best fit
Adults with type 2 diabetes or metabolic syndrome
Time
8–16 weeks

inflammatory biomarker reduction

Limited Evidence
Effect
Small reductions in CRP and TNF-alpha in some meta-analyses
Best fit
Adults with elevated baseline inflammatory markers
Time
8–16 weeks

Evidence for 3 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

cardiovascular biomarker improvement

Biomarker support
Limited Evidence

Meta-analyses of RCTs show small and inconsistent improvements in total cholesterol, LDL, triglycerides, and blood pressure with resveratrol. Some trials show reductions in CRP and improved endothelial function. Results are heterogeneous and effect sizes are generally modest. No cardiovascular outcome trial has been conducted. Poor bioavailability of oral resveratrol likely limits effects at typical supplement doses.

Effect size
Small and inconsistent improvements in lipid, inflammatory, and endothelial markers
Time to effect
8–24 weeks
Best fit
Adults with cardiovascular risk factors (dyslipidemia, hypertension)
Less likely
Healthy adults with no cardiovascular risk — benefit is not established

Bottom line: Inconsistent biomarker signals; no evidence of cardiovascular disease prevention in humans.

Evidence is mixed

Meta-analyses are split — some report positive lipid and inflammatory biomarker changes, others find no significant effect. The heterogeneity likely reflects differences in dose, formulation, and population.

insulin sensitivity and glucose metabolism

Biomarker support
Limited Evidence

Some RCTs and meta-analyses report modest improvements in fasting glucose, insulin sensitivity (HOMA-IR), and HbA1c with resveratrol at 5002,000 mg/day in people with metabolic disease. The mechanism involves AMPK and SIRT1 activation. However, not all meta-analyses show significant effects, and trial heterogeneity is high.

Effect size
Modest and inconsistent HOMA-IR reductions in some trials
Time to effect
8–16 weeks
Best fit
Adults with type 2 diabetes or metabolic syndrome
Less likely
Healthy normoglycemic adults

Bottom line: Modest glucose and insulin biomarker improvements in metabolic disease — inconsistent and not established for clinical outcomes.

inflammatory biomarker reduction

Biomarker support
Limited Evidence

Resveratrol inhibits NF-kB and COX-2 pathways in cell models. Clinical meta-analyses show modest reductions in hs-CRP and TNF-alpha in RCTs. Effect sizes are small and results are inconsistent across trials. There is no evidence of clinical benefit (reduced inflammatory disease activity) from these biomarker changes.

Effect size
Small reductions in CRP and TNF-alpha in some meta-analyses
Time to effect
8–16 weeks
Best fit
Adults with elevated baseline inflammatory markers

Bottom line: Small inflammatory biomarker reductions seen in some meta-analyses; clinical relevance is unestablished.

How it works

Resveratrol's biological activities derive from its polyphenolic stilbene structure, which allows it to scavenge free radicals and modulate enzyme activity. The most-discussed mechanism is activation of sirtuins, particularly SIRT1, a family of NAD-dependent deacetylases that influence cellular stress responses, inflammation, and metabolism. Whether resveratrol activates sirtuins directly or indirectly through AMPK and energy-sensing pathways remains debated. Resveratrol also inhibits cyclooxygenase enzymes (COX-1 and COX-2), modulates nitric oxide signaling, and may influence estrogen receptors. In preclinical studies, it has shown effects on blood vessel function, mitochondrial biogenesis, and gene expression patterns associated with caloric restriction. A major practical limitation is bioavailability. Oral resveratrol is rapidly absorbed but undergoes extensive first-pass metabolism in the liver and gut, yielding primarily sulfate and glucuronide conjugates with low free resveratrol in the bloodstream. This explains why some preclinical effects do not consistently appear in human trials at typical supplement doses. Trans-resveratrol is the bioactive isomer; cis-resveratrol has limited activity.

How to take it

1. Typical dose
100–500 mg/day of trans-resveratrol
2. Higher studied dose
Up to 2,000 mg/day in some metabolic trials; GI side effects increase markedly
3. Timing
With a fat-containing meal for modestly improved absorption
4. With food
With food — improves lipophilic absorption and reduces GI upset at higher doses
5. Split dosing
Twice-daily dosing may help maintain blood levels given short half-life
6. How long to try
8–24 weeks to assess metabolic biomarker effect; reevaluate need regularly

What to track

Fasting glucose and insulin (if targeting metabolic benefit)
Lipid panel
GI tolerance (nausea, diarrhea — common at doses over 500 mg)
Blood pressure

3 commercial forms

Compare the main delivery options and what they’re best suited for.

Trans-resveratrol

Typically extracted from Japanese knotweed. Look for standardized trans-resveratrol content.

The biologically active isomer; should be the primary form in supplements.

Micronized / formulated resveratrol

May offer modestly improved absorption over standard powder forms.

Smaller particle size or combined with absorption enhancers like piperine or fat carriers.

Liposomal resveratrol

Higher cost; bioavailability advantages are documented but the clinical significance is unclear.

Phospholipid encapsulation designed to improve absorption.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Nausea, diarrhea, abdominal cramps (especially at doses over 500 mg)Flatulence

Who should avoid it

Pregnancy & breastfeeding

Avoid during pregnancy — potential estrogenic activity raises developmental safety concerns; insufficient human safety data.

Interactions

Warfarin and antiplatelet drugs (aspirin, clopidogrel)Moderate

Mild antiplatelet and anticoagulant potentiation; increased bleeding risk

Cyclosporine and statinsModerate

CYP3A4 inhibition may raise drug levels; monitor for side effects

AntihypertensivesMinor

Mild blood pressure lowering may add to antihypertensive effect

Hormone therapy and oral contraceptivesMinor

Estrogenic receptor activity may interact with hormonal therapies

Documented interactions

Protocols featuring Resveratrol

Evidence-backed routines where Resveratrol plays a role.

Food sources

Red wine

Amount
5 oz glass
%DV

Red grapes (with skin)

Amount
1 cup
%DV

Peanuts

Amount
1 oz
%DV

Pistachios

Amount
1 oz
%DV

Blueberries

Amount
1 cup
%DV

Cranberries

Amount
1 cup
%DV

Dark chocolate

Amount
1 oz
%DV

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for

Trans-resveratrol (not cis-resveratrol — cis has minimal biological activity)
Source stated: Japanese knotweed (Polygonum cuspidatum) or grape skin extract
Percentage of trans-resveratrol per dose clearly stated

Be skeptical of

"Activates sirtuins for longer life" — human longevity data does not exist
"Like drinking red wine without the alcohol" — dietary wine doses of resveratrol are far too small to be pharmacologically active
"Proven anti-aging" — preclinical data has not translated to proven human aging benefits

Frequently asked questions

How much resveratrol is in red wine?

Red wine contains roughly 0.2 to 2 mg of resveratrol per 5-oz glass, depending on grape variety and production. To match doses used in supplement research, you would need to drink impractical amounts of wine.

Does resveratrol really slow aging?

There is no human evidence that resveratrol extends lifespan or slows aging. Preclinical studies in yeast and rodents are intriguing but have not translated reliably to humans at typical supplement doses.

What is the best dose of resveratrol?

Most clinical studies have used 100 to 500 mg per day. Higher doses do not clearly offer more benefit and increase GI side effects. Look for products specifying trans-resveratrol content.

Should I take resveratrol with food?

Taking with a fat-containing meal may improve absorption since resveratrol is fat-soluble. Some research suggests fasting may slightly increase peak blood levels, but the practical difference is modest.

Can resveratrol interact with my medications?

Yes. Resveratrol can affect cytochrome P450 enzymes and may interact with blood thinners, blood pressure medications, statins, and others. Consult your pharmacist or doctor if you take prescription medications.

References by claim

cardiovascular biomarker improvement

Liu et al., 2015PubMed (2015) link

Teimouri et al., 2022PubMed (2022) link

insulin sensitivity and glucose metabolism

Liu et al., 2014PubMed (2014) link

Delpino et al., 2022PubMed (2022) link

inflammatory biomarker reduction

Koushki et al., 2018PubMed (2018) link

Tabrizi et al., 2018PubMed (2018) link

Safety

Memorial Sloan Kettering — ResveratrolMSKCC About Herbs link

Track Resveratrol with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.